[et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_fullwidth_slider _builder_version=”4.27.4″ _module_preset=”default” background_enable_image=”off” custom_padding=”150px||150px|||” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][et_pb_slide heading=”Welcome to the Trivieri Lab” use_bg_overlay=”off” _builder_version=”4.27.4″ _module_preset=”default” background_image=”https:\/\/labs.icahn.mssm.edu\/trivierilab\/wp-content\/uploads\/sites\/360\/2025\/08\/Composite-3.jpg” background_enable_image=”on” global_colors_info=”{}” sticky_transition=”on”]<\/p>\n
The Trivieri Lab focuses on investigating key molecular mechanisms responsible for the onset and progression of Cardiomyopathy, Pulmonary Hypertension, and Hereditary Hemorrhagic Telangiectasia, using state-of-the-art techniques in stem cell biology, tissue engineering, and molecular imaging.<\/p>\n
[\/et_pb_slide][\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”||||||||” header_font=”||||||||” header_3_font=”||||||||” header_3_text_color=”#8300E9″ hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
Cardiovascular diseases remain one of the leading causes of death worldwide, yet the molecular mechanisms behind many of these conditions, like cardiomyopathy, Pulmonary Hypertension (PH), and Hereditary Hemorrhagic Telangiectasia (HHT), are still not fully understood.<\/p>\n
Located within the Cardiovascular Research Institute at the Icahn School of Medicine at Mount Sinai, the Trivieri Lab is driven by the need to bridge this gap using cutting-edge tools in stem cell biology, molecular imaging, and tissue engineering to build more accurate disease models, identify new therapeutic targets, and bring science closer to clinical solutions.<\/p>\n
Our work is guided by the belief that translational research, grounded in strong biology and advanced technology, has the power to improve lives.<\/p>\n